Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market

Retrieved on: 2024-04-18 15:16:24

Tags for this article:

Click the tags to see associated articles and topics

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market. View article details on hiswai:

Excerpt

The clinical-stage biotech ... The company's portfolio is sourced from a proprietary library of 20,000 gut hormone peptides and peptide/antibody ...

Article found on: www.biospace.com